Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) trials recruiting in Massachusetts

Fewer than 3 recruiting trials found.

All Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) trials nationally

1

Recruiting in Massachusetts

1

Cities with sites

Cities in Massachusetts

Boston 1

Recruiting trials in Massachusetts

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
NCT05652686 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.